Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Kym I.E. Snell, Douglas G. Ward, Naheema S. Gordon, James C. Goldsmith, Andrew J. Sutton, Prashant Patel, Nicholas D. James, Maurice P. Zeegers, K.K. Cheng, Richard T. Bryan
Published May 18, 2018 · Vol. 9, No. 38 · pp. 25244-25253
Emilie M.J. van Brummelen, Marc C. Huisman, Linda J. de Wit-van der Veen, Tapan K. Nayak, Marcel P.M. Stokkel, Emma R. Mulder, Otto S. Hoekstra, Danielle J. Vugts, Guus A.M.S. Van Dongen, Henk M. Verheul, Stefan Evers, Jean J.L. Tessier, Jose Saro, Jan H.M. Schellens, C. Willemien Menke-van der Houven van Oordt
Published May 15, 2018 · Vol. 9, No. 37 · pp. 24737-24749
Mirelle Lagendijk, Sepideh Sadaatmand, Linetta B. Koppert, Madeleine M.A. Tilanus-Linthorst, Vanja de Weerd, Raquel RamÃrez-Moreno, Marcel Smid, Anieta M. Sieuwerts, John W.M. Martens
Published May 11, 2018 · Vol. 9, No. 36 · pp. 24335-24346